Print | Need Larger Text? | Share

Description - Figure 7 - Consultation Document - Draft Guidance Document: Preparation of Drug Regulatory Activities in Electronic Common Technical Document (eCTD)

Figure 7 is an illustration of how the related-sequence-number is used to describe the relationship of additional information to the original and subsequent regulatory activities.
Sequence number is e123454;
Sequence number is 0000, related sequence number is (----, control number is 123454, information type is original regulatory activity, sample document is pre-submission meeting;
Sequence number is 0001, related sequence number is (0000, control number 123454, information type is solicited information, sample document is meeting minutes;
Sequence number is 0002, related sequence number is (----, control number 123455, information type is subsequent regulatory activity, sample document is priority review request;
Sequence number is 0003, related sequence number is (----, control number 123456, information type is subsequent regulatory activity, sample document is new drug submission;
Sequence number is 0004, related sequence number is (0003, control number 123456, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0005, related sequence number is (0003, control number 123456, information type is solicited information, sample document is response to notice of deficiency;
Sequence number is 0006, related sequence number is (0003, control number 123456, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0007, related sequence number is (0003, control number 123456, information type is solicited information, sample document is Safety update;
Sequence number is 0008, related sequence number is (0003, control number 123456, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0009, related sequence number is (0003, control number 123456, information type is solicited information, sample document is pristine product monograph;
Sequence number is 0010, related sequence number is (----, control number 123555, information type is subsequent regulatory activity, sample document is supplemental to a new drug submission;
Sequence number is 0011, related sequence number is (0010, control number 123555, information type is solicited information, sample document is response to Notice of Non-Compliance;
Sequence number is 0012, related sequence number is (----, control number 123666, information type is subsequent regulatory activity, sample document is notifiable change;
Sequence number is 0013, related sequence number is (0010, control number 123555, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0014, related sequence number is (----, control number 123579, information type is subsequent regulatory activity, sample document is subsequent regulatory activity;
Sequence number is 0015, related sequence number is (0012, control number 123666, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0016, related sequence number is (0012, control number 123666, information type is solicited information, sample document is response to request for clarification;
Sequence number is 0017, related sequence number is (0012, control number 123666, information type is solicited information, sample document is pristine product monograph;
Sequence number is 0018, related sequence number is (----, control number ------, information type is subsequent regulatory activity, sample document is Level III changes;
Sequence number is 0019, related sequence number is (----, control number 123721-, information type is subsequent regulatory activity, sample document is Yearly Biologic Product Reports;